Tandem Diabetes Care Pumps Up Sales Dramatically in Q2
Tandem Diabetes Care (NASDAQ: TNDM) enjoyed a solid first quarter with revenue jumping a whopping 142% year over year. And the company's net loss decreased to $23 million from the prior-year period of $32.7 million.
Investors wondering if Tandem would be able to keep up this momentum in the second quarter had their questions were answered when the company reported its Q2 results after the market closed on Thursday. Here's what you need to know about Tandem's Q2 update.
Image source: Tandem Diabetes Care.
Quelle Fool.com
